NVCR Q4 2021 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q4 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$133M-7.5% YoY

Gross Profit

$104M77.7% margin

Operating Income

-$23M-17.6% margin

Net Income

-$26M-19.9% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

-0.3%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$130,000

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$729M

Stockholders' Equity

$410M

Cash & Equivalents

$210M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$133M	$144M	-7.5%
Gross Profit	$104M	$116M	-10.6%
Operating Income	-$23M	$12M	-293.5%
Net Income	-$26M	$5M	-638.1%

Geographic Segments

UNITED STATES

$92M73%

GERMANY

$19M15%

JAPAN

$9M7%

CHINA

$6M5%